Abstract
Cefotaxime treatment eliminates normally susceptible strains of enterobacteria from the digestive tract, and increases intestinal carriage of resistant enterobacteria in individuals. However the global rate of such carriage remains low in hospitalized patients and resistant strains are exceptionally isolated from bacteraemia in spite of an intensive use of this antibiotic. The epidemiology of resistant strains of enterobacteria has to be carefully monitored. The results obtained by the control of faecal carriage shows that this technique is a means of surveying evolution in this area.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
